Full Text View
Tabular View
No Study Results Posted
Related Studies
Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in Pregnancy (DMA)
This study is currently recruiting participants.
Verified November 2012 by University of Oxford
Study NCT01054248   Information provided by University of Oxford

First Received on January 21, 2010.   Last Updated on November 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
dihydroartemisinin-piperaquine
Artesunate-mefloquine
arthemeter-lumefantrin
Additional drug interventions recognized in this trial
Artemether
Artemether-lumefantrine combination
Artemisinins
Artesunate
Dihydroquinghaosu
Lumefantrine
Mefloquine
Piperaquine
More general drug interventions related to this trial
Amebicides
Anthelmintics
Anti-Infective Agents
Antifungal Agents
Antimalarials
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Coccidiostats
Pharmacologic Actions
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
University of Oxford


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services